Industry Connect with CSL

UQ researchers are cordially invited to attend an information session or tune into scheduled webinars to hear Dr Marthe D’Ombrain of CSL launch their
2020 Research Acceleration Initiative.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and UQ, and other Australian research organisations.

The initiative focuses on early stage projects that have potential to impact therapies for patients in CSL’s therapeutic areas, focus areas and modalities of interest (see below)

Successful applicants will receive up to $250,000 per year for up to 2 years (max $500,000 funding) to accelerate translation of their research.

Therapeutic areas

Immunology
Neurology
Haematology
Thrombosis
Transplant
Respiratory
Cardiovascular/metabolic

Focus areas

Novel drug targets
Novel therapeutic candidates
Novel strategies for treating disease

Modalities

Antibodies
Protein therapeutics
Gene therapies
Cell therapies
Small molecules are not of interest

Event details

Time

1:00pm - 2:30pm

Date

Tuesday, 18 February 2020

Venue

Room 275, Level 2
Global Change Institute (#20)
Staff House Road
St Lucia Campus

RSVP

rsvp@uniquest.com.au
by Friday, 14 February 2020

Webinar details

Time

12:00pm - 1:00pm

11:30am - 12:30pm

Date

Monday, 17 February 2020

Thursday, 20 February 2020

Webinar links

For webinar link details please email

p.harpur@uniquest.com.au

Contact us

Contact us for more information about this and other Industry Connect events.

Contact us